EEG Biomarkers for Chronic Lower Back Pain
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to better understand chronic lower back pain by studying brain activity using EEG, a test that detects electrical activity in the brain. Researchers will examine brain patterns related to emotions and thinking to predict changes in symptoms over time. Participants will undergo EEG tests both at rest and during specific tasks to gather this information. Those with a current diagnosis of chronic low back pain may join, but individuals with cancer or severe psychiatric issues cannot participate. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new insights and treatments for chronic pain.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these EEG techniques are safe for studying chronic lower back pain?
Research has shown that using EEG (a test that records brain activity) in studies on chronic pain, such as chronic lower back pain, is generally safe and well-tolerated. Different types of EEG tests, including Picture Viewing EEG, Resting State EEG, and Stop Signal EEG, have demonstrated positive results without serious safety concerns.
In a large study with 614 participants, Picture Viewing EEG did not cause any severe side effects, indicating it is a safe method for studying brain activity in people with chronic pain.
Several studies have reviewed Resting State EEG and found it helpful for diagnosing chronic pain without significant side effects. This method involves monitoring brain activity while participants are relaxed and is generally considered safe.
The Stop Signal EEG was tested in a controlled study and found to be safe and acceptable, with no major safety issues reported.
Overall, research supports the safety of using EEG to study chronic pain, including chronic lower back pain. These findings suggest that participants in EEG studies can expect a safe and comfortable experience.12345Why are researchers excited about this trial?
Researchers are excited about the EEG techniques being explored for chronic lower back pain because these methods aim to provide a deeper understanding of brain activity related to pain. Unlike standard treatments like medication or physical therapy, which primarily address symptoms, these EEG approaches—Picture Viewing EEG, Resting State EEG, and Stop Signal EEG—focus on identifying specific brain activity patterns linked to pain. By doing so, they could lead to more personalized and effective treatment plans in the future, potentially offering insights that current options cannot.
What evidence suggests that these EEG methods are effective for predicting chronic lower back pain progression?
Research has shown that EEG, a test measuring brain activity, can help predict chronic low back pain and its symptoms. Studies have found that EEG can detect differences in brain activity between individuals with chronic low back pain and those without it. For example, changes in brain activity and connections have been observed in specific brain areas of those with chronic low back pain. One study found that specific EEG features, such as peak alpha frequency, might indicate a person's sensitivity to pain. These findings suggest that EEG could be a valuable tool for understanding and managing chronic low back pain by identifying key brain patterns. In this trial, participants will complete interventions involving Picture Viewing EEG, Resting State EEG, and Stop Signal EEG to further explore these biomarkers.26789
Are You a Good Fit for This Trial?
This trial is for adults with chronic low back pain (CLBP) who can speak English. It's not suitable for individuals with cancer, severe psychiatric conditions, those involved in injury litigation or receiving workers' compensation benefits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline EEG and neuropsychological assessments are conducted
Follow-up
Participants undergo EEG and neuropsychological assessments at 1-month and 2-month follow-ups
Extended Follow-up
Participants are assessed for patient-reported outcomes at a 5-month follow-up
What Are the Treatments Tested in This Trial?
Interventions
- Picture Viewing EEG
- Resting State EEG
- Stop Signal EEG
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Collaborator